Xu Boning, Zhang Chunxin, Wei Wei, Zhan Yun, Yang Mingguo, Wang Yanjun, Zhao Jiajian, Lin Guiyang, Zhang Wen-Wen, Huo Xing, Shi Bin, Fan Ling
Cardiovascular Department, The Fifth Clinical College of China Medical University-Bengang General Hospital of China Resources Medical Group, Benxi, China.
Cath Lab, The Fifth Clinical College of China Medical University-Bengang General Hospital of China Resources Medical Group, Benxi, China.
Front Cardiovasc Med. 2023 Oct 4;10:1249924. doi: 10.3389/fcvm.2023.1249924. eCollection 2023.
To investigate the impact of optimized thrombus aspiration on myocardial perfusion, prognosis, and safety in patients with acute STsegment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention(primary PCI).
A total of 129 patients with STEMI were randomly allocated into control group (Subgroup A and B) and experimental group(Subgroup C and D). Control group received percutaneous transluminal coronary angioplasty (PTCA),thrombus aspiration and primary PCI. Experimental group received optimized thrombus aspiration and primary PCI. The number of thrombus aspiration was less than 4 times in Subgroup A and C. The number of thrombus aspiration was performed more than 4 times in Subgroups B and D. The classification of thrombi extracted, the TIMI flow grade, the incidence of no-reflow and slow flow, cTFC, TPI and CK-MB at 12 h and 24 h after stenting, ST segment resolution of ECG after stenting, NT-proBNP, LVEFat 24 h, 30 days and 180 days after stenting were compared between groups. The incidence of intraoperative and postoperative bleeding complications, stroke events and major cardiovascular events (MACE) were recorded and compared between groups.
The classification of thrombi extracted in the experimental group was higher than that in the control group. The TIMI flow grade of the experimental group was better than the control group after thrombus aspiration. After stenting, the advantage still existed, but the difference was not statistically significant. On cTFC, the experimental group was lower than the control group, but the difference was not statistically significant; After stenting the experimental group was significantly lower than the control group. The CK-MB at 12 h and 24 h of the experimental group was lower than the control group. After thrombus aspiration the incidence of no-reflow in the experimental group was significantly lower than that in the control group; after stenting the incidence of no-reflow in the experimental group was still lower than the control group, but no statistically difference. After thrombus aspiration and stenting the incidence of slow flow in the experimental group were lower than that in the control group. After stenting, NT-proBNP at 24 h was lower in the experimental group than that in the control group, However, there was no statistical difference; after stenting, The NT-proBNP in the experimental group was lower than that in the control group at 30 days and 180 days. After stenting, LVEF of the experimental group was significantly higher than the control group at 24 h and 30 days; superiority remained after 180 days but no statistical difference. There was no statistical difference between two groups for intraoperative and postoperative bleeding complications, stroke events, and MACE events. In Subgroup analysis,there was no significant difference in the classification of thrombi extracted, TIMI flow grade, cTFC, CK-MB,NT-proBNP and LVEF between group C and D, but group A was better than group B. Analysis of variance showed that the optimal number of suction was 4-5 times.
Optimized thrombus aspiration can significantly improve myocardial perfusion and short-term and medium-term prognosis of STEMI patients after PCI, and reduce the incidence of slow flow and no-reflow. The optimal suction times were 4-5 times. Traditional aspiration method with more aspiration times is harmful to cardiac prognosis. Thrombus aspiration does not increase the incidence of stroke events and is safe.: identifier, ChiCTR2300073410.
探讨优化血栓抽吸对接受直接经皮冠状动脉介入治疗(直接PCI)的急性ST段抬高型心肌梗死(STEMI)患者心肌灌注、预后及安全性的影响。
将129例STEMI患者随机分为对照组(A、B亚组)和试验组(C、D亚组)。对照组接受经皮腔内冠状动脉成形术(PTCA)、血栓抽吸及直接PCI。试验组接受优化血栓抽吸及直接PCI。A、C亚组血栓抽吸次数少于4次。B、D亚组血栓抽吸次数超过4次。比较两组间抽出血栓的分类、TIMI血流分级、无复流和慢血流发生率、支架置入后12小时和24小时的校正TIMI帧数(cTFC)、心肌灌注指数(TPI)及肌酸激酶同工酶(CK-MB)、支架置入后心电图ST段回落情况、N末端B型利钠肽原(NT-proBNP)、支架置入后24小时、30天和180天的左室射血分数(LVEF)。记录并比较两组术中及术后出血并发症、卒中事件及主要心血管事件(MACE)的发生率。
试验组抽出血栓的分类高于对照组。试验组血栓抽吸后TIMI血流分级优于对照组。支架置入后,优势依然存在,但差异无统计学意义。cTFC方面,试验组低于对照组,但差异无统计学意义;支架置入后试验组显著低于对照组。试验组12小时和24小时的CK-MB低于对照组。血栓抽吸后试验组无复流发生率显著低于对照组;支架置入后试验组无复流发生率仍低于对照组,但无统计学差异。血栓抽吸及支架置入后试验组慢血流发生率低于对照组。支架置入后,试验组24小时的NT-proBNP低于对照组,但无统计学差异;支架置入后30天和180天试验组的NT-proBNP低于对照组。支架置入后,试验组24小时和30天的LVEF显著高于对照组;180天后优势依然存在,但无统计学差异。两组术中及术后出血并发症、卒中事件及MACE事件无统计学差异。亚组分析显示,C组和D组在抽出血栓的分类、TIMI血流分级、cTFC、CK-MB、NT-proBNP及LVEF方面无显著差异,但A组优于B组。方差分析显示最佳抽吸次数为4 - 次。
优化血栓抽吸可显著改善STEMI患者PCI术后的心肌灌注及短期和中期预后,并降低慢血流和无复流的发生率。最佳抽吸次数为4 - 5次。抽吸次数较多的传统抽吸方法对心脏预后有害。血栓抽吸不增加卒中事件的发生率且安全。试验注册号:ChiCTR2300073410 。